In this medical video learn how a new treatment for Leukemia is making waves in the medical world.
Read the full transcript »
Jennifer Matthews: Norman Zobel has been carving wood for 20 years. Norman Zobel: I can sit and wood carve, and I can think about the things I want to do. It kind of clears my mind to think about the things that I have to do. Jennifer Matthews: He's needed the escape. Seven years ago, Norman was diagnosed with chronic lymphocytic leukemia. Norman Zobel: It was very traumatic. The first thing I asked him is, how long have I got? How long will I live? Jennifer Matthews: The answer is changing right before Zobel's eyes. Dr. Asher Chanan-Khan enrolled Norman in a study on a new drug called lenalidomide. Asher Chanan-Khan: This particular drug is an oral drug. It's not chemotherapy, it's not associated with any nausea, vomiting, loss of hair. Jennifer Matthews: Lenalidomide has mild side effects and is a powerful player against leukemia that has grown resistant to other therapies. Asher Chanan-Khan: With the first dose, patients started to respond. Jennifer Matthews: The drug changes the environment around cancer cells, making it tough for the cells to survive. It was effective in nearly half of people who had run out of treatment options. Asher Chanan-Khan: We have several patients now in whom we cannot detect cancer anymore. Jennifer Matthews: Norman is one of them. Norman Zobel: When the doctor comes up to you and says, you are in complete remission and you are safe from the problem you've had,' it's hard to put into words. Jennifer Matthews: Now, with his wife by his side, Zobel is finally looking forward to his future. This is Jennifer Matthews reporting.